EUVIMEDOpdag EUVIMED
Open access

Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation

Chih-Jie Shen, Ren-Hao Chan, Bo-Wen Lin, Nien-Chi Li, Ying-Hsuan Huang, Wen-Chang Chang, Ben-Kuen Chen

Theranostics · 2023

DOI: 10.7150/thno.85855 ↗

At a glance

Journal article in Theranostics, 2023. Written by Chih-Jie Shen and 6 co-authors. Institution: Graduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei 110, Taiwan, ROC. Major MEDLINE topics: Colonic Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Cited 8 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Multigene mutations in colorectal cancer (CRC), including KRAS, BRAF, and p53, afford high metastatic ability and resistance to EGFR-targeting therapy. Understanding the molecular mechanisms regulating anti-EGFR-resistant CRC metastasis can improve CRC therapy. This study aimed to investigate the effects of IL-8 and the activation of KRAS on reactive oxygen species (ROS) production and metastasis of hyperlipidemia-associated CRC harboring mutations of KRAS and p53.

Methods

The cytokine array analysis determined the up-expression of secreted factors, including IL-8. The clinical relevance of the relationship between IL-8 and angiopoietin-like 4 (ANGPTL4) was examined in CRC patients from National Cheng Kung University Hospital and TCGA dataset. Expressions of IL-8, ANGPTL4, NADPH oxidase 4 (NOX4), and epithelial-mesenchymal transition (EMT) markers in free fatty acids (FFAs)-treated KRAS/p53 mutant CRC cells were determined. The hyperlipidemia-triggered metastatic ability of CRC cells under treatments of antioxidants, statin, and cetuximab or knockdown of IL-8, KRAS, and EGFR was evaluated in vitro and in vivo. In addition, the effects of antioxidants and depletion of IL-8 and KRAS on the correlation between ROS production and hyperlipidemia-promoted CRC metastasis were also clarified.

Results

In this study, we found that free fatty acids promoted KRAS/p53-mutant but not single-mutant or non-mutant CRC cell metastasis. IL-8, the most abundant secreted factor in KRAS/p53-mutant cells, was correlated with the upregulation of NOX4 expression and ROS production under oleic acid (OA)-treated conditions. In addition, the metastasis of KRAS/p53-mutant CRC relies on the ANGPTL4/IL-8/NOX4 axis and the activation of KRAS. The antioxidants and inactivation of KRAS also inhibited OA-induced EMT and metastasis. Although KRAS mediated EGF- and OA-promoted CRC cell invasion, the inhibition of EGFR did not affect OA-induced ANGPTL4/IL-8/NOX4 axis and CRC metastasis. The high-fat diet mice fed with vitamin E and statin or in IL-8-depleted cells significantly inhibited tumor extravasation and metastatic lung growth of CRC.

Conclusion

The antioxidants, statins, and targeting IL-8 may provide better outcomes for treating metastatic CRC that harbors multigene mutations and anti-EGFR resistance.

Subjects

MeSH terms (MEDLINE)

Colonic NeoplasmsHydroxymethylglutaryl-CoA Reductase InhibitorsAnimalsMiceAntibodiesAntioxidantsFatty Acids, NonesterifiedInterleukin-8Oleic AcidsProto-Oncogene Proteins p21(ras)Reactive Oxygen SpeciesTumor Suppressor Protein p53Humans

Author keywords

IL-8KRAS activationmetastasismultigene mutant CRColeic acid

Substances

AntibodiesAntioxidantsFatty Acids, NonesterifiedHydroxymethylglutaryl-CoA Reductase InhibitorsInterleukin-8Oleic AcidsProto-Oncogene Proteins p21(ras)Reactive Oxygen SpeciesTumor Suppressor Protein p53

Authors and institutions

  • Graduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei 110, Taiwan, ROC.
  • Division of Colorectal Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan, ROC.
  • Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan, ROC.

Cite

APA

Shen, C. J., Chan, R. H., Lin, B. W., Li, N. C., Huang, Y. H., Chang, W. C., & Chen, B. K. (2023). Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation. Theranostics. https://doi.org/10.7150/thno.85855

Vancouver

Shen CJ, Chan RH, Lin BW, Li NC, Huang YH, Chang WC, et al. Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation. Theranostics. 2023. doi:10.7150/thno.85855

BibTeX
@article{Shen2023,
  author = {Shen, Chih-Jie and Chan, Ren-Hao and Lin, Bo-Wen and Li, Nien-Chi and Huang, Ying-Hsuan and Chang, Wen-Chang and Chen, Ben-Kuen},
  title = {Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.85855}
}
Start for free →